产品名称 | Retatrutide (Peptide Reference) 瑞塔鲁肽 |
---|---|
目录号 | NBS-233797 |
别名 | LY3437943 |
外观 | White to off-white solid powder |
分子量 | 4732.33 |
CAS | 2381089-83-2 |
溶解度 | see COA |
存储条件 | Store at -20℃ |
保存时间 | see COA |
备注1 | |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBS-233797-1mg | 1mg | 咨询 | 咨询 | |
NBS-233797-5mg | 5mg | 咨询 | 咨询 | |
NBS-233797-100mg | 100mg | 咨询 | 咨询 | |
NBS-233797-1g | 1g | 咨询 | 咨询 | |
NBS-233797-Bulk | Bulk | 咨询 | 咨询 |
NebuPeptide™ Retatrutide (Peptide Reference)
品名:NebuPeptide™ Retatrutide (Peptide Reference)
货号:NBS-233797
品牌:Nebulabio
规格:1mg;5mg;100mg;1g;Bulk
别名:LY3437943
产品描述
NebuPeptide™ Retatrutide (Peptide Reference)(CAT#NBS-233797) is synthesized in accordance with the Retatrutide sequence and can be utilized for a variety of in vivo and in vitro studies, including quality control, bioactivity verification, immunization, drug development, structural analysis, etc. Nebula Biotechnology Co., Ltd. is capable of providing Eptifibatide reference peptide ranging from milligrams to kilograms.
Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic peptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50s of 5.79, 0.0643 and 0.775 nM respectively. Retatrutide may be used in obesity research.
更多详情请咨询→
全国免费热线:3499拉斯维加斯ls
直拨专线:136-9140-9741;132-6921-9473
客服QQ一:3279280667;
客服QQ二:1877748443
公司地址:北京市经济技术开发区西环南路26号院嘉捷企业汇30号楼A座6层603-9室
咨询和订购邮箱:info@vicbio.com